
Sign up to save your podcasts
Or


The team discusses growing economic concerns, including weak labor data revisions, rising delinquencies, and increasing odds of a Fed rate cut. The conversation also covers key developments in healthcare, highlighting Eli Lilly's GLP-1 drug updates, and tech earnings from companies like Shopify, AMD, and Snap. The episode explores the narrow market leadership dominated by AI-fueled megacaps and raises questions about its sustainability. It also dives into AI's expanding role in consumer apps, fashion, and media, along with a closer look at rising consumer credit stress and what it signals for the broader economy.
By AMI Asset ManagementThe team discusses growing economic concerns, including weak labor data revisions, rising delinquencies, and increasing odds of a Fed rate cut. The conversation also covers key developments in healthcare, highlighting Eli Lilly's GLP-1 drug updates, and tech earnings from companies like Shopify, AMD, and Snap. The episode explores the narrow market leadership dominated by AI-fueled megacaps and raises questions about its sustainability. It also dives into AI's expanding role in consumer apps, fashion, and media, along with a closer look at rising consumer credit stress and what it signals for the broader economy.